You thought you were being discreet. You wanted help for your hair loss, your weight, your erectile dysfunction, and you didn’t want to talk to your family doctor about it. So you went to a sleek, modern telehealth app that promised absolute privacy. You trusted them with your deepest insecurities. And they sold you out.
When your business model relies on treating human vulnerability as a monetizable asset, privacy violations aren’t a bug—they’re the entire feature.
The FTC just dropped a bombshell lawsuit against Hims & Hers. The allegation? The company promised users discretion for their most sensitive health concerns, then turned around and handed that exact data over to social media giants for targeted advertising.
Most commentary is focusing on the ‘betrayal of trust.’ But that misses the bigger, uglier picture. This isn’t a rogue employee making a bad call. This is the direct-to-consumer (DTC) telehealth model functioning exactly as designed.
You aren’t the patient in a DTC telehealth clinic; you are the product in a highly optimized vulnerability-harvesting machine.
Think about how these companies operate. They offer cheap, frictionless access to medications. They spend millions on Instagram and TikTok ads. How do they afford to give you that $20-a-month generic prescription? They subsidize the cost by selling your data back to the ad networks that brought you there in the first place. They tell Meta you bought ED meds. They tell TikTok you’re taking weight loss drugs. Then, those platforms use that data to target you, and millions of others just like you, with even more ads.
If a digital health platform promises you discretion while simultaneously buying ads on the world’s most invasive networks, they are lying to your face.
If you use any telemedicine or digital health platform right now, this should terrify you. The Hims & Hers case isn’t an isolated incident; it’s a precedent. It exposes the systemic conflict between user trust and revenue incentives. These apps market themselves as safe havens, but their balance sheets demand they act as surveillance pipelines.
We are entering an era of AI-driven advertising where every click, every symptom, every prescription is a data point to be auctioned off. The FTC lawsuit is a warning shot, but the structural incentives remain. Next time you see a sleek ad promising a ‘discreet, private’ solution to your personal health struggles, remember what that promise is actually worth.
FAQ
Q: Doesn't HIPAA protect my medical data on these apps?
A: HIPAA protects data shared with your doctor, but the moment a telehealth app shares tracking data with third-party ad networks under the guise of 'marketing,' they exploit massive legal gray areas. The FTC is stepping in because federal health privacy laws haven't kept pace with ad-tech.
Q: Should I delete my telehealth apps?
A: Not necessarily, but you need to treat them like public forums. Never assume a DTC health app offers the same legal and ethical privacy as a traditional doctor's office. Use ad-blockers, separate emails, and assume your purchase history is being tracked.
Q: Isn't it a fair trade for cheaper meds?
A: No, because the trade isn't transparent. If they explicitly said, 'We'll give you cheap ED meds if you let us tell Facebook about your condition,' users would flee. They rely on the illusion of privacy to harvest the data that funds their discounts.